GPR182 is a Broadly Scavenging Atypical Chemokine Receptor Influencing T-independent Immunity
Overview
Authors
Affiliations
Immune responses highly depend on the effective trafficking of immune cells into and within secondary lymphoid organs (SLOs). Atypical chemokine receptors (ACKRs) scavenge chemokines to eliminate them from the extracellular space, thereby generating gradients that guide leukocytes. In contrast to canonical chemokine receptors, ACKRs do not induce classical intracellular signaling that results in cell migration. Recently, the closest relative of ACKR3, GPR182, has been partially deorphanized as a potential novel ACKR. We confirm and extend previous studies by identifying further ligands that classify GPR182 as a broadly scavenging chemokine receptor. We validate the "atypical" nature of the receptor, wherein canonical G-protein-dependent intracellular signaling is not activated following ligand stimulation. However, β-arrestins are required for ligand-independent internalization and chemokine scavenging whereas the C-terminus is in part dispensable. In the absence of GPR182 , we observed elevated chemokine levels in the serum but also in SLO interstitium. We also reveal that CXCL13 and CCL28, which do not bind any other ACKR, are bound and efficiently scavenged by GPR182. Moreover, we found a cooperative relationship between GPR182 and ACKR3 in regulating serum CXCL12 levels, and between GPR182 and ACKR4 in controlling CCL20 levels. Furthermore, we unveil a new phenotype in GPR182-KO mice, in which we observed a reduced marginal zone (MZ), both in size and in cellularity, and thus in the T-independent antibody response. Taken together, we and others have unveiled a novel, broadly scavenging chemokine receptor, which we propose should be named ACKR5.
Inclusion of ACKR5 in the systematic nomenclature of atypical chemokine receptors.
Szpakowska M, Legler D, Offermanns S, Sozzani S, Rot A, Thelen M Nat Rev Immunol. 2025; 25(3):225-226.
PMID: 39900975 DOI: 10.1038/s41577-025-01135-8.
Russo R, Ryffel B Cells. 2025; 13(24).
PMID: 39768150 PMC: 11674266. DOI: 10.3390/cells13242058.
Atypical chemokine receptors in the immune system.
Comerford I, McColl S Nat Rev Immunol. 2024; 24(10):753-769.
PMID: 38714818 DOI: 10.1038/s41577-024-01025-5.
Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5).
Bonnavion R, Liu S, Kawase H, Roquid K, Offermanns S Front Pharmacol. 2023; 14:1297596.
PMID: 38026988 PMC: 10646305. DOI: 10.3389/fphar.2023.1297596.
Chemokines, molecular drivers of thromboinflammation and immunothrombosis.
Leberzammer J, von Hundelshausen P Front Immunol. 2023; 14:1276353.
PMID: 37954596 PMC: 10637585. DOI: 10.3389/fimmu.2023.1276353.